PHARMAC has completed the review and are pleased to present the outcome, which is a new framework for PHARMAC’s decision-making.

The key features of the framework are as follows:

• A new diagram presenting 15 factors for consideration will replace the current list of nine decision criteria;
• PHARMAC will take into account factors that impact on the person receiving the medicine or medical device; the impact on family, whanāu of the person and wider society; and the impact on the broader health system;
• PHARMAC will consider the impact on the health of Māori as a separate factor to acknowledge our commitment to Te Tiriti o Waitangi;
• PHARMAC will consider the health impact on a broader group of populations that are facing health disparities; this includes the significant disparities that currently exist with New Zealand’s Pacific populations.

A supporting information document provides additional explanation for each of the factors for consideration.

For more details, go to: http://www.pharmac.health.nz/news/notification-2014-11-24-decision-criteria-review/